Pancreatic Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults who do not currently have any symptoms and are attending a health facility for a routine check-up or a scheduled cancer screening (or both)
- People who are able to understand what the study involves and are willing to sign a consent form before taking part
Who may not be able to join:
- People who have already been diagnosed with pancreatic cancer
- People who are unwilling or unable to have certain follow-up scans (such as an MRI, an internal ultrasound, or a CT scan) if an initial test result comes back positive
- People who have a medical, mental health, or personal/social situation that the lead doctor at the trial site believes would make taking part unsuitable or could affect how the study runs (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Keiji Hanada, MD, Ph.D., JA Onomichi General Hospital
Phone: +81-3-6823-2260
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Pancreatic Cancer Detection Rate
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.